 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 641 - 650 of 2187:
FDA Completes Final Analysis Of "Total Body Formula" And "Total Body Mega Formula" Products
The U.S. Food and Drug Administration's final analysis of certain flavors of "Total Body Formula" and "Total Body Mega Formula" has detected hazardous...
FDA Confirms Infant-Meds Recall
Three months after a group of pharmaceutical companies voluntarily recalled cough and cold medicine for children under the age of 2, the Food & Drug A...
FDA Confirms No Heart Risk From Heartburn Drugs
A U.S. government review of the popular heartburn drugs Prilosec and Nexium found no evidence of increased heart risks, health officials said Monday. ...
FDA confirms salmonella in Kellogg peanut butter snack
The Food and Drug Administration said Monday that salmonella was found in a package of peanut butter sandwich crackers made by Kellogg (K).Kellogg (K)...
FDA Confirms Salmonella In The Melons
The U.S. Food and Drug Administration has come out and confirmed that melons from Agropecuaria Montelibano in Honduras have tested positive for salmon...
FDA Considering Biomarkers As a Way to Improve Drug Safety
A new way of testing experimental drugs is being considered by the Food & Drug Administration (FDA). If adopted, the FDA could end up requiring “bioma...
FDA considers combo allergy pill
A single tablet formulation combining two major allergy treatments has been accepted for review by the US Food and Drug Administration (FDA). The n...
FDA considers reforming use, selection of advisory panels
Federal advisers who met last week to consider whether to restrict doses of popular antianemia drugs were themselves under scrutiny during the hearing...
FDA Considers Regulation of Salt
The FDA has completed a public hearing where it received public feedback into a proposal to regulate salt as a food additive and remove its "generally...
FDA Considers Updating Label For Anticlotting Drug Plavix
Amid recent studies showing the anti-clotting drug Plavix may not be effective for 30% of cardiac patients, federal regulators are considering updatin... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |